Anti-Smoking Vaccine Trialled in Sweden
A new vaccine against nicotine dependency is to go on wide scale trial for the first time.
Swedish newspaper, Svenska Dagbladet, reports that the vaccine developed by the company Independent Pharmaceutica together with researchers at the Karolinska Institute is to be tested on people in Scandinavia to help them to try and stop smoking. Researchers are currently searching for 400 smokers who want to kick the habit.
The vaccine works on the principle that the body’s immune defences will develop anti-bodies against nicotine that prevent the drug reaching the brain and therefore stop the smoker from getting the nicotine rush they crave.
It is hoped that the vaccine will create long lasting anti-bodies in the patient’s immune system and may be used as a conventional aid to helping people to quit smoking in the future.